Mail

UK markets closed

FTSE 100
8,213.49
+41.34(+0.51%)
FTSE 250
20,164.54
+112.21(+0.56%)
AIM
771.53
+3.42(+0.45%)
GBP/EUR
1.1652
-0.0031(-0.26%)
GBP/USD
1.2546
+0.0013(+0.11%)
Bitcoin GBP
50,784.64
+656.12(+1.31%)

Best savings accounts that offer above inflation rates

Where to find a top-rated deal that works for you

Titan Medical Inc. (TMD.TO)

Toronto - Toronto Real-time price. Currency in CAD

Add to watchlist

0.0500

-0.0100

(-16.67%)

At close: 09:37AM EDT

Currency in CAD

Valuation measures⁴

Market cap (intra-day)	5.70M
Enterprise value	-2.80M
Trailing P/E	0.61
Forward P/E	N/A
PEG ratio (5-yr expected)	N/A
Price/sales (ttm)	0.24
Price/book (mrq)	0.87
Enterprise value/revenue	-0.16
Enterprise value/EBITDA	-0.38

Trading information

Stock price history

Beta (5Y monthly)	1.98
52-week change ³	-68.42%
S&P500 52-week change ³	22.38%
52-week high ³	0.2600
52-week low ³	0.0500
50-day moving average ³	0.0778
200-day moving average ³	0.1154

Share statistics

Avg vol (3-month) ³	66.55k
Avg vol (10-day) ³	59.73k
Shares outstanding ⁵	114.04M
Implied shares outstanding ⁶	114.04M
Float ⁸	113.56M
% held by insiders ¹	0.42%
% held by institutions ¹	0.37%
Shares short (15 Apr 2024) ⁴	44.7k
Short ratio (15 Apr 2024) ⁴	0.4
Short % of float (15 Apr 2024) ⁴	0.04%
Short % of shares outstanding (15 Apr 2024) ⁴	0.04%
Shares short (prior month 15 Mar 2024) ⁴	31.42k

Dividends & splits

Forward annual dividend rate ⁴	N/A
Forward annual dividend yield ⁴	N/A
Trailing annual dividend rate ³	0.00
Trailing annual dividend yield ³	0.00%
5-year average dividend yield ⁴	N/A
Payout ratio ⁴	0.00%
Dividend date ³	19 Jun 2018
Ex-dividend date ⁴	N/A
Last split factor ²	1:30
Last split date ³	19 Jun 2018

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends	31 Dec 2023
Most-recent quarter (mrq)	31 Dec 2023

Profitability

Profit margin	39.43%
Operating margin (ttm)	368.00%

Management effectiveness

Return on assets (ttm)	81.50%
Return on equity (ttm)	857.87%

Income statement

Revenue (ttm)	17.63M
Revenue per share (ttm)	0.16
Quarterly revenue growth (yoy)	N/A
Gross profit (ttm)	N/A
EBITDA	10.54M
Net income avi to common (ttm)	6.95M
Diluted EPS (ttm)	0.0800
Quarterly earnings growth (yoy)	N/A

Balance sheet

Total cash (mrq)	7.59M
Total cash per share (mrq)	0.07
Total debt (mrq)	1.32M
Total debt/equity (mrq)	27.65%
Current ratio (mrq)	2.78
Book value per share (mrq)	0.04

Cash flow statement

Operating cash flow (ttm)	4.68M
Levered free cash flow (ttm)	1.79M